Is the treatment of CIN 2 always necessary in women under 25 years old?
- PMID: 21872201
- DOI: 10.1016/j.ajog.2011.06.069
Is the treatment of CIN 2 always necessary in women under 25 years old?
Abstract
Objective: The purpose of this study was to review the outcome of conservatively managed cervical intraepithelial neoplasia (CIN) 2 in women <25 years old.
Study design: This was a retrospective review that included women who were <25 years old with biopsy proven CIN2 between 2005 and 2009. Analysis was performed that compared women who had immediate treatment with women whose treatment was deferred >4 months. The primary outcome measure was spontaneous regression of CIN2. Secondary outcomes were treatment rates and loss to follow-up evaluation.
Results: Of the 452 women who were identified, 256 women (57%) received immediate treatment; 157 women (35%) met the definition for conservative management, and 39 women (9%) had unknown subsequent management. Of the 157 women who were managed conservatively, 98 women (62%) showed spontaneous regression, with a median of 8 months observation. No conservatively managed women progressed to cancer.
Conclusion: Based on the 62% regression rate in this study, routine treatment may not be necessary for all women with CIN2 who are <25 years old.
Copyright © 2011 Mosby, Inc. All rights reserved.
Comment in
-
Initial diagnosis of CIN 2-should patients be managed expectatively?Am J Obstet Gynecol. 2012 Mar;206(3):e11; author reply e11-2. doi: 10.1016/j.ajog.2011.11.003. Epub 2011 Nov 12. Am J Obstet Gynecol. 2012. PMID: 22177189 No abstract available.
Similar articles
-
Regression and Progression Predictors of CIN2 in Women Younger Than 25 Years.J Low Genit Tract Dis. 2016 Jul;20(3):213-7. doi: 10.1097/LGT.0000000000000215. J Low Genit Tract Dis. 2016. PMID: 27203702
-
Conservative management of biopsy confirmed high-grade squamous intraepithelial lesions.Bratisl Lek Listy. 2017;118(12):732-735. doi: 10.4149/BLL_2017_138. Bratisl Lek Listy. 2017. PMID: 29322804
-
Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia.Acta Obstet Gynecol Scand. 2016 Mar;95(3):291-8. doi: 10.1111/aogs.12835. Epub 2016 Jan 17. Acta Obstet Gynecol Scand. 2016. PMID: 26660398
-
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2. Cochrane Database Syst Rev. 2017. PMID: 28125861 Free PMC article. Review.
-
Management options for cervical intraepithelial neoplasia.Best Pract Res Clin Obstet Gynaecol. 2011 Oct;25(5):641-51. doi: 10.1016/j.bpobgyn.2011.04.007. Epub 2011 Jun 30. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21723198 Review.
Cited by
-
Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia and its association with high-grade histopathological recurrence after cervical excision in women with negative excision margins: a systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Mar;309(3):939-948. doi: 10.1007/s00404-023-07242-y. Epub 2023 Oct 11. Arch Gynecol Obstet. 2024. PMID: 37821642 Free PMC article. Review.
-
Association Between Cervical Cancer Screening Guidelines and Preterm Delivery Among Females Aged 18 to 24 Years.JAMA Health Forum. 2023 Jul 7;4(7):e231974. doi: 10.1001/jamahealthforum.2023.1974. JAMA Health Forum. 2023. PMID: 37477927 Free PMC article.
-
Absence of high-grade cervical intraepithelial neoplasia in conization specimens from patients with colposcopic biopsy-confirmed high-grade cervical intraepithelial neoplasia: Retrospective study of 1695 cases.Front Oncol. 2022 Sep 14;12:980884. doi: 10.3389/fonc.2022.980884. eCollection 2022. Front Oncol. 2022. PMID: 36185239 Free PMC article.
-
Burden of CIN2+ diagnoses and conizations in women aged 18-45 years-a retrospective secondary data analysis of German statutory health insurance claims data.Arch Gynecol Obstet. 2022 Dec;306(6):2077-2092. doi: 10.1007/s00404-022-06548-7. Epub 2022 Apr 14. Arch Gynecol Obstet. 2022. PMID: 35420356 Free PMC article.
-
Comparison of Expectant and Excisional/Ablative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in the Era of HPV Testing.Obstet Gynecol Int. 2022 Mar 24;2022:7955290. doi: 10.1155/2022/7955290. eCollection 2022. Obstet Gynecol Int. 2022. PMID: 35371262 Free PMC article.
